AstraZeneca

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
astrazeneca

Some of the key events about AstraZeneca

  • 1913
    The company was founded as Astra AB in Södertälje, Sweden
  • 1999
    Astra AB merged with Zeneca Group to form AstraZeneca
  • 1999
    Paid $355 million to settle allegations of Medicare fraud
  • 2003
    Faced criticism for allegedly suppressing negative clinical trial data for the antidepressant Seroquel
  • 2004
    Launched Crestor, a highly effective cholesterol-lowering drug
  • 2007
    Acquired MedImmune, expanding its biologics and vaccines capabilities
  • 2010
    Paid $520 million to settle allegations of off-label marketing of the antipsychotic drug Seroquel
  • 2011
    Received FDA approval for Brilinta, a blood-thinning medication for acute coronary syndromes
  • 2011
    Agreed to pay $68.5 million to settle allegations of deceptive marketing practices for Seroquel
  • 2013
    Faced accusations of bribing doctors in China to boost drug sales
  • 2014
    Successfully fended off a takeover attempt by Pfizer, maintaining its independence
  • 2014
    Paid $110 million to settle allegations of violating the Foreign Corrupt Practices Act in multiple countries
  • 2015
    Acquired ZS Pharma, strengthening its cardiovascular and metabolic disease portfolio
  • 2016
    Agreed to pay $5.5 million to resolve allegations of violating a previous corporate integrity agreement
  • 2019
    Launched Calquence for the treatment of chronic lymphocytic leukemia
  • 2020
    Developed a COVID-19 vaccine in collaboration with Oxford University
  • 2020
    Faced criticism for delays and supply shortages in COVID-19 vaccine production for the European Union
  • 2021
    Acquired Alexion Pharmaceuticals, expanding into rare disease treatments
  • 2021
    Several European countries temporarily suspended use of AstraZeneca's COVID-19 vaccine due to blood clot concerns
  • 2021
    Criticized for selling its stake in Moderna for $1 billion before the COVID-19 pandemic, missing out on larger gains

Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.

AstraZeneca Latest news